Home
OTLK
OTLK News

Latest Outlook Therapeutics Inc. (OTLK) News on November 24, 2024

Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference

GlobeNewswire

18 days ago

Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference

Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment

GlobeNewswire

a month ago

Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 10/01/2024

Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series

GlobeNewswire

2 months ago

Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series

Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series

GlobeNewswire

2 months ago

Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series

Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial

GlobeNewswire

3 months ago

Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Outlook Therapeutics Inc Earnings Call

Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

GlobeNewswire

3 months ago

Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire

3 months ago

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Why Is Caligan Partners Bullish on Outlook Therapeutics Inc (OTLK) Right Now?

Insider Monkey

3 months ago

Why Is Caligan Partners Bullish on Outlook Therapeutics Inc (OTLK) Right Now?

Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2024 and Host Quarterly Conference Call and Webcast

GlobeNewswire

4 months ago

Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2024 and Host Quarterly Conference Call and Webcast

Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024

GlobeNewswire

4 months ago

Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024

MT Newswires

5 months ago

Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

GlobeNewswire

5 months ago

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%

Simply Wall St.

5 months ago

Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%

Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference

GlobeNewswire

5 months ago

Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference

MT Newswires

6 months ago

Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

GlobeNewswire

6 months ago

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Thomson Reuters StreetEvents

6 months ago

Q2 2024 Outlook Therapeutics Inc Earnings Call

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

GlobeNewswire

6 months ago

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

MT Newswires

6 months ago

Outlook Therapeutics Submits Marketing Application for Wet Age-related Macular Degeneration Therapy in UK

Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire

6 months ago

Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast

GlobeNewswire

6 months ago

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast

Outlook Therapeutics® to Present at the Retina World Congress 2024

GlobeNewswire

7 months ago

Outlook Therapeutics® to Present at the Retina World Congress 2024

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase

GlobeNewswire

7 months ago

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase

Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors

Barrons.com

7 months ago

Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

GlobeNewswire

7 months ago

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

Insiders are Piling into These 10 Healthcare Stocks in 2024

Insider Monkey

7 months ago

Insiders are Piling into These 10 Healthcare Stocks in 2024

Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire

8 months ago

Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

GlobeNewswire

8 months ago

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split

GlobeNewswire

8 months ago

Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split

7 of the Best Speculative Stocks You Can Snag for Less Than $1

InvestorPlace

9 months ago

7 of the Best Speculative Stocks You Can Snag for Less Than $1

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

InvestorPlace

9 months ago

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

GuruFocus.com

9 months ago

Outlook Therapeutics Inc (OTLK) Reports Q1 Fiscal 2024 Results and Strategic Developments

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update

GlobeNewswire

9 months ago

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update

Eos Energy Enterprises Join Forces with SABIC Specialties to Produce a Specialty Light-Weight, Conductive Composite Thermoplastic for Eos Z3TM Battery

GlobeNewswire

10 months ago

Eos Energy Enterprises Join Forces with SABIC Specialties to Produce a Specialty Light-Weight, Conductive Composite Thermoplastic for Eos Z3TM Battery

Outlook Therapeutics® Doses First Subject in NORSE EIGHT

GlobeNewswire

10 months ago

Outlook Therapeutics® Doses First Subject in NORSE EIGHT

Powerfleet and MiX Telematics Announce Shareholders Meetings to Vote on Proposed Business Combination

PR Newswire

10 months ago

Powerfleet and MiX Telematics Announce Shareholders Meetings to Vote on Proposed Business Combination

Here's What We Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming Dividend

Simply Wall St.

10 months ago

Here's What We Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming Dividend

HYZON DELIVERS FIRST FOUR FUEL CELL ELECTRIC VEHICLES TO PERFORMANCE FOOD GROUP

PR Newswire

10 months ago

HYZON DELIVERS FIRST FOUR FUEL CELL ELECTRIC VEHICLES TO PERFORMANCE FOOD GROUP

Associated Press Finance

10 months ago

Alerus: Q4 Earnings Snapshot

Alerus Financial Corp (ALRS) Reports Q4 Loss and Balance Sheet Repositioning

GuruFocus.com

10 months ago

Alerus Financial Corp (ALRS) Reports Q4 Loss and Balance Sheet Repositioning

Alerus Financial Corporation Announces Fourth Quarter 2023 Results, Including Balance Sheet Repositioning

Business Wire

10 months ago

Alerus Financial Corporation Announces Fourth Quarter 2023 Results, Including Balance Sheet Repositioning

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Zacks

10 months ago

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

NewMediaWire

10 months ago

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

GlobeNewswire

10 months ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Hear from Ciaran Long, CFO of a.k.a. Brands Live at ICR Conference 2024

IPO-Edge.com

10 months ago

Hear from Ciaran Long, CFO of a.k.a. Brands Live at ICR Conference 2024

FirstSun, HomeStreet to merge

Banking Dive

10 months ago

FirstSun, HomeStreet to merge

HomeStreet to sell itself after tough year

American Banker

10 months ago

HomeStreet to sell itself after tough year

Armada Hoffler To Discuss Fourth Quarter Earnings On February 22nd

GlobeNewswire

10 months ago

Armada Hoffler To Discuss Fourth Quarter Earnings On February 22nd

LuxUrban Hotels to Present at Upcoming Investor Conferences

Business Wire

10 months ago

LuxUrban Hotels to Present at Upcoming Investor Conferences

The 3 Best Biotech Stocks to Buy in January 2024

InvestorPlace

10 months ago

The 3 Best Biotech Stocks to Buy in January 2024

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas

ACCESSWIRE

10 months ago

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas

Qurate CEO Talks Turnaround and Growth Plans

WWD

10 months ago

Qurate CEO Talks Turnaround and Growth Plans

VIZSLA SILVER ANNOUNCES SIGNIFICANT INCREASE IN CONTAINED OUNCES AND INCREASE IN GRADE OF INDICATED CATEGORY TO 551 G/T AGEQ IN UPDATED MINERAL RESOURCES ESTIMATE

CNW Group

a year ago

VIZSLA SILVER ANNOUNCES SIGNIFICANT INCREASE IN CONTAINED OUNCES AND INCREASE IN GRADE OF INDICATED CATEGORY TO 551 G/T AGEQ IN UPDATED MINERAL RESOURCES ESTIMATE

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

GlobeNewswire

a year ago

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

Alimera Completes Recruitment for the Synchronicity Study

GlobeNewswire

a year ago

Alimera Completes Recruitment for the Synchronicity Study

Relmada Therapeutics Provides Corporate Update

PR Newswire

a year ago

Relmada Therapeutics Provides Corporate Update

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign

Investor's Business Daily

a year ago

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

GlobeNewswire

a year ago

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

Verint Systems Inc Chairman & CEO Dan Bodner Sells 13,171 Shares

GuruFocus.com

a year ago

Verint Systems Inc Chairman & CEO Dan Bodner Sells 13,171 Shares

Verint Open CCaaS Platform Named Best Customer Engagement Solution in UC Today Partner Awards

Business Wire

a year ago

Verint Open CCaaS Platform Named Best Customer Engagement Solution in UC Today Partner Awards

Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010

GlobeNewswire

a year ago

Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010

Eos Energy Announces Launch of Proposed $40M Public Offering

GlobeNewswire

a year ago

Eos Energy Announces Launch of Proposed $40M Public Offering

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

GlobeNewswire

a year ago

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

Eos Energy and Pine Gate Renewables Announce Partnership Expansion

GlobeNewswire

a year ago

Eos Energy and Pine Gate Renewables Announce Partnership Expansion

PR Newswire

a year ago

THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION AT NEW RATE OF $0.129 PER SHARE

Forrester Opens Nominations For Its 2024 Customer Obsession Awards

PR Newswire

a year ago

Forrester Opens Nominations For Its 2024 Customer Obsession Awards

Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade

Outlook Therapeutics® Announces Strategic Organizational Realignment

GlobeNewswire

a year ago

Outlook Therapeutics® Announces Strategic Organizational Realignment

Forrester: European Retail Sales To Reach €2.7 Trillion By 2028

Business Wire

a year ago

Forrester: European Retail Sales To Reach €2.7 Trillion By 2028

Business Wire

a year ago

Energy Vault Receives Successful Technical Due Diligence Evaluation for the Bankability of B-VAULT™ Battery Energy Storage System from Global Authority DNV

Business Wire

a year ago

Energy Vault Announces Participation at the Shareholder Equity Conference

Adaptimmune Receives Transfer of IND for Lete-cel Program

Newsfile

a year ago

Adaptimmune Receives Transfer of IND for Lete-cel Program

Loss-Making Outlook Therapeutics, Inc. (NASDAQ:OTLK) Expected To Breakeven In The Medium-Term

Simply Wall St.

a year ago

Loss-Making Outlook Therapeutics, Inc. (NASDAQ:OTLK) Expected To Breakeven In The Medium-Term

Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010

GlobeNewswire

a year ago

Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010

First Guaranty Bancshares (NASDAQ:FGBI) Is Due To Pay A Dividend Of $0.16

Simply Wall St.

a year ago

First Guaranty Bancshares (NASDAQ:FGBI) Is Due To Pay A Dividend Of $0.16

Baozun (BZUN) Q3 2023 Earnings Call Transcript

Motley Fool

a year ago

Baozun (BZUN) Q3 2023 Earnings Call Transcript

Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?

Simply Wall St.

a year ago

Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?

Business Wire

a year ago

Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

25 Highest Quality Furniture Brands in the World

Insider Monkey

a year ago

25 Highest Quality Furniture Brands in the World

Business Wire

a year ago

ADTRAN Holdings, Inc. to Meet with Investors at the Deutsches Eigenkapitalforum 2023 on November 27-28, 2023

Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.13 Per Share

GlobeNewswire

a year ago

Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.13 Per Share

Adtran integrates Intel NetSec Accelerator Reference Design with Ensemble Cloudlet to enable edge cluster nodes and deliver edge cloud performance

Business Wire

a year ago

Adtran integrates Intel NetSec Accelerator Reference Design with Ensemble Cloudlet to enable edge cluster nodes and deliver edge cloud performance

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

Business Wire

a year ago

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates

Zacks

a year ago

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates

Business Wire

a year ago

Energy Vault Reports Third Quarter 2023 Financial Results

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million

GuruFocus.com

a year ago

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million

Energy Vault, Wellhead and W Power Begin Commercial Operations of Stanton Battery Energy Storage System

Business Wire

a year ago

Energy Vault, Wellhead and W Power Begin Commercial Operations of Stanton Battery Energy Storage System

Citizens, Inc. Reports Third Quarter 2023 Financial Results

Newsfile

a year ago

Citizens, Inc. Reports Third Quarter 2023 Financial Results

Share on Social Networks: